FCL - Fineotex Chem
📢 Recent Corporate Announcements
Fineotex Chemical Limited (FCL) has announced a change in its registered office address within the local limits of Mumbai. The office has moved from Bandra (West), PIN 400050, to a new location at Ariisto House in Andheri (East), PIN 400069. This update was filed on March 07, 2026, in compliance with Regulation 30 of SEBI Listing Regulations. This is a routine administrative relocation and does not affect the company's business operations or financial performance.
- Registered office relocated from Bandra (West) to Ariisto House, Andheri (East), Mumbai
- The move is within the local limits of the city of Mumbai
- Compliance maintained under Regulation 30 of SEBI (LODR) Regulations, 2015
- Announcement dated March 07, 2026, with no impact on core business activities
Fineotex Chemical Limited (FCL) has announced its participation in the Arihant Capital – Bharat Connect Conference Rising Stars 2026. The virtual group meeting is scheduled for Tuesday, March 10, 2026, starting at 02:00 P.M. IST. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during this interaction. This event is part of the company's routine investor relations activities to engage with institutional investors and analysts.
- Meeting scheduled for March 10, 2026, at 02:00 P.M. IST via virtual mode.
- Participation in the Arihant Capital – Bharat Connect Conference Rising Stars 2026.
- The interaction will be conducted as a group meeting with various analysts and investors.
- Company confirms that no unpublished price sensitive information will be disclosed.
- Disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Fineotex Chemical (FCL) reported a robust 46% YoY revenue growth to ₹190 crores in Q3 FY26, driven by a significant surge in export share which rose to 48%. The company successfully completed the acquisition of US-based CrudeChem Technologies, adding 80,000 MTPA capacity and expanding its presence in the high-margin oil and gas sector. Despite the acquisition, FCL remains debt-free with a strong cash balance of ₹340 crores. Promoters further demonstrated confidence by converting warrants worth ₹17.3 crores during the quarter.
- Revenue increased 46% YoY to ₹190 crores for Q3 FY26 with export share nearly doubling to 48%.
- Acquisition of CrudeChem Technologies adds 80,000 MTPA capacity and approximately $65 million in annual sales potential.
- Maintained a healthy cash position of ₹340 crores and remains debt-free post-acquisition.
- Promoters infused ₹17.3 crores through warrant conversion, signaling strong long-term commitment.
- Business mix shifted to 55% Textiles, 30% Specialty Oilfield, and 15% Cleaning and Hygiene.
Fineotex Chemical Limited (FCL) has made the audio recording of its Q3 FY 2025-26 investor and analyst conference call available to the public. The call, held on February 16, 2026, focused on the company's financial performance and operational updates for the third quarter. This disclosure is in compliance with SEBI (LODR) Regulations, 2015, ensuring transparency for all stakeholders. Investors can access the recording via the company's website to hear management's detailed commentary on the business outlook.
- Audio recording of the Q3 FY 2025-26 earnings call released on February 16, 2026.
- Compliance with SEBI (LODR) Regulation 46(2)(oa) regarding investor meet disclosures.
- The recording covers management's discussion on financial performance for the quarter ended December 2025.
- Direct access link provided for the MP3 recording on the official Fineotex website.
Fineotex Chemical Limited (FCL) has significantly scaled its global manufacturing capacity to 2,00,000 MTPA, largely driven by the acquisition of a 53.33% stake in the US-based CCT Group. The CCT Group reported a revenue of $67.4 million in FY25, providing FCL with a strategic foothold in the North American oil and gas specialty chemicals market. The company remains debt-free and recently completed a 4:1 bonus issue and 1:2 stock split to enhance equity liquidity. Currently, 44% of FCL's revenue is generated from sustainable 'green chemistry' portfolios across its textile, oilfield, and cleaning segments.
- Total manufacturing capacity reached 2,00,000 MTPA across India, USA, and Malaysia, including a new 15,000 MTPA facility commissioned in August 2025.
- Acquired 53.33% controlling stake in US-based CrudeChem Technologies (CCT Group) which had FY25 revenue of $67.4 million.
- Maintains a debt-free balance sheet with an upgraded ICRA credit rating of A+ (Positive) and A1+ (Positive).
- Diversified business model with 44% of revenue now derived from eco-friendly green chemistries.
- Promoters participated in a significant fundraise of Rs. 3,425.5 million via preferential allotment to fuel growth.
Fineotex Chemical (FCL) reported a strong Q3 FY26 with consolidated revenue growing 45.49% YoY to ₹190.46 crore and PAT increasing 8.23% YoY to ₹30.12 crore. The company achieved a significant volume growth of 39% YoY and maintained a healthy ROIC of 26.82%. A major highlight is the successful acquisition of US-based CrudeChem Technologies, expanding FCL's footprint into the global oil and gas specialty chemicals sector. Additionally, the company strengthened its balance sheet through warrant conversions amounting to approximately ₹35.68 crore.
- Consolidated Revenue from operations grew 45.49% YoY to ₹19,046 Lakhs, supported by 39% volume growth.
- Profit After Tax (PAT) rose 15.50% on a QoQ basis to ₹3,012 Lakhs.
- Successfully completed the acquisition of US-based CrudeChem Technologies (CCT Group) for global expansion.
- Consolidated Return on Invested Capital (ROIC) for Q3 FY26 stood at a healthy 26.82%.
- Received ₹35.68 crores from warrant conversions; 12.51 lakh unexercised warrants were cancelled.
Fineotex Chemical Limited (FCL) has scheduled an interaction with institutional investors and analysts on February 17, 2026. The management will be participating in the Ambit Global Private Clients Upnext Conference 2026, starting at 10:00 AM IST. This in-person group meeting is part of the company's regular investor relations outreach. The company has confirmed that no unpublished price sensitive information (UPSI) will be shared during the session.
- Participation in Ambit Global Private Clients Upnext Conference 2026 scheduled for Feb 17, 2026.
- The meeting is set to commence at 10:00 AM IST in an in-person group format.
- Compliance disclosure made under Regulation 30 of SEBI (LODR) Regulations, 2015.
- Company explicitly stated that no unpublished price sensitive information will be disclosed.
Fineotex Chemical Limited (FCL) has scheduled its earnings conference call for February 16, 2026, at 4:00 PM IST to discuss financial results for Q3 and 9M FY2025-26. The call will feature key management personnel including Executive Director Aarti Jhunjhunwala, CEO Arindam Choudhuri, and CFO Sanjay Tibrewala. This routine regulatory filing provides a platform for institutional investors and analysts to gain insights into the company's operational performance. Investors will be looking for updates on the specialty chemicals segment and margin trends.
- Earnings conference call scheduled for February 16, 2026, at 4:00 PM IST.
- Agenda includes discussion on operational and financial performance for Q3 and 9M FY26.
- Key management participants include the Executive Director, CEO (Textile), and CFO.
- International dial-in numbers provided for investors in USA, UK, Singapore, and Hong Kong.
Fineotex Chemical Limited (FCL) has allotted 50,00,000 equity shares to Intuitive Alpha Investment Fund following the conversion of 5,00,000 warrants, receiving a balance payment of Rs 14.53 crore. A significant development is the forfeiture of 23,15,049 unexercised warrants, which allows the company to retain Rs 22.42 crore previously received as subscription money. Post-allotment, the company's paid-up capital has increased to Rs 116.45 crore, with promoter holding at 61.87%. The forfeiture provides a substantial cash boost to the company's reserves without further equity dilution.
- Allotment of 50,00,000 equity shares at an adjusted issue price of Rs 38.74 per share.
- Receipt of Rs 14.53 crore representing the final 75% balance for warrant conversion.
- Forfeiture of 23,15,049 unexercised warrants, resulting in a non-refundable gain of Rs 22.42 crore.
- Total paid-up capital increased to 116.45 crore equity shares of Rs 1 each.
- Promoter shareholding post-allotment stands at 61.87%.
Fineotex Chemical Limited (FCL) has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by Bigshare Services Private Limited, confirms that all share certificates received for dematerialization during the quarter ended December 31, 2025, were processed appropriately. The Registrar and Share Transfer Agent (RTA) verified that the securities were listed on the stock exchanges and physical certificates were mutilated and cancelled. This is a standard procedural filing ensuring the integrity of the company's shareholding records.
- Compliance certificate submitted for the quarter ended December 31, 2025.
- Confirmation provided by Registrar and Share Transfer Agent (RTA), Bigshare Services Pvt. Ltd.
- Securities received for dematerialization were confirmed and listed on the stock exchanges.
- Physical certificates were mutilated and cancelled within the mandated 15-day period of receipt.
- The name of the depositories has been substituted in the register of members as the registered owner.
Fineotex Chemical Limited (FCL) has announced the closure of its trading window starting January 1, 2026, in compliance with SEBI Insider Trading regulations. This closure is a precursor to the declaration of the company's financial results for the quarter ending December 31, 2025. The restriction applies to all directors, designated employees, and their immediate relatives to prevent insider trading. The window will remain closed until 48 hours after the financial results are officially disclosed to the stock exchanges.
- Trading window closure begins on January 1, 2026, for the quarter ending December 31, 2025.
- Restriction applies to all Directors, Designated employees, and their immediate relatives.
- Window will reopen 48 hours after the official declaration of quarterly financial results.
- Compliance is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Fineotex Chemical Limited (FCL) has acquired a 53.33% controlling stake in the US-based CrudeChem Technologies (CCT) group for approximately $11.5 million. The acquired entities report a combined annual revenue of $68 million, making the deal highly EPS-accretive with a low price-to-sales ratio of approximately 0.3x. This strategic move targets the $11.5 billion North American oilfield chemicals market and aligns with FCL's goal to build a $200 million oilfield specialty chemicals business. Financial consolidation is expected to begin effectively from January 1, 2026.
- Acquired 53.33% controlling stake in four US-based specialty chemical companies for $11.5 million
- Target group generates combined annual revenue of $68 million with a debt-free balance sheet
- Deal is immediately EPS-accretive and values the target at a low 0.3x Price-to-Sales ratio
- FCL aims to scale the oilfield specialty chemicals segment to a $200 million business globally
- Approximately 25-30% of the acquisition value will be infused as primary capital for growth
Fineotex Chemical Limited (FCL) has entered into a definitive agreement to acquire a 53.33% controlling stake in the US-based CrudeChem Technologies group for approximately $11.5 million. The acquired entities report a combined annual revenue of $68 million, indicating a highly attractive acquisition valuation of approximately 0.3x price-to-sales. This strategic move provides FCL with immediate access to the $11.5 billion North American oilfield chemicals market and Tier 1 global energy producers. The acquisition is expected to be immediately EPS-accretive and supports FCL's long-term goal of building a $200 million oilfield chemicals business.
- Acquired 53.33% controlling stake in four US-based specialty chemical companies for $11.5 million.
- The target group generates $68 million in annual revenue and is currently debt-free.
- Transaction is EPS-accretive with consolidation expected to begin from January 1, 2026.
- Provides strategic entry into the $11.5 billion North American oilfield chemicals market.
- Management plans additional investments of over $10 million in US plant and machinery for future growth.
Fineotex Chemical Limited has announced the availability of the audio recording of its Investor/Analyst call held on December 10, 2025. The call discussed the acquisition of a Leading U.S. Specialty Oilfield Chemicals Group. The audio recording is accessible on the company's website. This information is pursuant to Regulation 46(2)(oa) of the SEBI (LODR) Regulations, 2015.
- Audio recording of Investor/Analyst Call held on December 10, 2025 is now available.
- The call discussed the Acquisition of a Leading U.S. Specialty Oilfield Chemicals Group.
- The announcement is pursuant to Regulation 46(2)(oa) of the SEBI (LODR) Regulations, 2015.
Fineotex Chemical Limited (FCL) has scheduled an Investor/Analyst conference call to discuss the acquisition of a leading U.S. Specialty Oilfield Chemicals Group. The conference call is scheduled for December 10, 2025, at 12:00 Noon (IST). Investors can participate via primary numbers +91 22 6280 1578, +91 22 7115 8899 or toll-free numbers for USA, UK, Singapore and Hong Kong. The call will include Ms. Aarti Jhunjhunwala, Mr. Sachin Bandodkar and Mr. Sanjay Tibrewala.
- Investor/Analyst Conference Call on December 10, 2025 at 12:00 Noon (IST)
- Primary Access Numbers: +91 22 6280 1578, +91 22 7115 8899
- Toll Free Number USA: 1 866 746 2133
- Participants include Ms. Aarti Jhunjhunwala, Mr. Sachin Bandodkar, Mr. Sanjay Tibrewala
Financial Performance
Revenue Growth by Segment
Consolidated revenue reached INR 569 Cr in FY2024, up 10% from INR 517 Cr in FY2023. The Textile segment historically contributed 88% of revenue, but the company is diversifying into Home Care, Hygiene, and Oil & Gas. H1 FY2026 revenue stood at INR 274.78 Cr, a slight decrease of 4.5% compared to INR 287.63 Cr in H1 FY2025.
Geographic Revenue Split
Domestic sales accounted for 75% of revenue in Q2 FY2026, while exports contributed 25%. The company has a presence in approximately 70 countries, with exports forming 22% of total revenue in FY2024.
Profitability Margins
Gross margins expanded to 38.45% in Q2 FY2026 from 33.53% in Q1 FY2026. Net Profit Margin was 21.3% in FY2024 compared to 17.3% in FY2023. Operating margins have been maintained in a range of 18-22% over the last five years due to cost pass-through abilities.
EBITDA Margin
EBITDA margin stood at 22.53% in Q2 FY2026, a sequential improvement of 415 basis points from 18.38% in Q1 FY2026. FY2024 EBITDA margin was 26.1%, up from 21.8% in FY2023.
Capital Expenditure
The company raised funds through a preferential allotment of equity shares and warrants in FY2024 to support liquidity and potential expansion. Specific historical INR Cr values for capex are not disclosed, but the company recently ramped up newly added capacities at Ambernath.
Credit Rating & Borrowing
ICRA upgraded FCL's rating to [ICRA]A (Positive) from [ICRA]A- (Stable). CRISIL maintains a rating of CRISIL A/Stable. Interest coverage ratio was robust at 111.5x in FY2024 and 178.63x in FY2025, reflecting minimal borrowing costs.
Operational Drivers
Raw Materials
Crude oil derivatives and specialty chemical intermediates. Raw material costs accounted for INR 175.87 Cr in H1 FY2026, representing approximately 64% of total revenue.
Import Sources
Raw materials are sourced from both domestic suppliers and international markets. Specific countries are not disclosed, though the company has manufacturing facilities in India and Malaysia.
Capacity Expansion
Current production volume stood at 60,692.40 MT in FY2024. The company has fungible manufacturing facilities in Navi Mumbai, Ambernath, and Selangor (Malaysia). Expansion is focused on ramping up utilization of these recently commissioned capacities.
Raw Material Costs
Raw material costs were INR 84.76 Cr in Q2 FY2026. The company manages volatility through formula-based pricing and a cost pass-through mechanism, allowing it to maintain operating margins despite crude oil price fluctuations.
Manufacturing Efficiency
Capacity utilization is being ramped up to drive cash generation. The company uses in-house R&D to improve product mix and raw material efficiencies, contributing to a 500 bps QoQ gross margin expansion in Q2 FY2026.
Strategic Growth
Expected Growth Rate
20%
Growth Strategy
Growth will be achieved through a 20% YoY volume target, ramping up the Ambernath facility, and diversifying into high-margin segments like Oil & Gas and FMCG (detergents). The company is leveraging JVs with Euroye-CTC and HealthGuard to expand its product portfolio and international footprint.
Products & Services
Specialty chemicals for textile pre-treatment, dyeing, printing, and finishing; detergents and handwashes for the health and hygiene segment; and drilling chemicals for the Oil & Gas industry.
Brand Portfolio
Biotex (Malaysia-based subsidiary), HealthGuard (JV partner brand).
New Products/Services
Recent entries include performance boosters for FMCG detergent companies and specialized drilling chemicals for the Oil & Gas sector, which are expected to contribute to higher gross margins.
Market Expansion
Targeting deeper penetration in the ~70 countries where it currently operates, with a focus on expanding the non-textile segment to balance the revenue profile.
Market Share & Ranking
FCL is a leading manufacturer of specialty and performance chemicals for textiles in India.
Strategic Alliances
Joint Ventures with Euroye-CTC and HealthGuard (Australia) to acquire new customers and diversify geographic presence.
External Factors
Industry Trends
The specialty chemicals industry is shifting toward sustainable and certified products. FCL is positioned for this through ZDHC and Blue Design certifications. The industry is growing, and FCL is moving from a textile-heavy focus to a balanced multi-segment profile.
Competitive Landscape
Faces intense competition from large European multinational players with high capital bases and established market dominance.
Competitive Moat
Moat is built on 40+ years of promoter experience, customized product offerings, and prestigious certifications (ZDHC, USEPA) that act as entry barriers. These are sustainable due to long-standing client relationships and technical expertise.
Macro Economic Sensitivity
Sensitive to global textile demand and household consumption trends. Geopolitical tensions can cause order postponements.
Consumer Behavior
Rising household consumption in India is driving demand for the company's home care and hygiene products.
Geopolitical Risks
Exposure to evolving US tariff environments and geopolitical instability in export regions which can delay shipments.
Regulatory & Governance
Industry Regulations
Subject to tightening environmental and safety regulations in the chemical industry. Compliance is maintained through Blue Design and Star Export House certifications.
Environmental Compliance
FCL is ZDHC Gateway certified and compliant with USEPA standards. CSR obligation for the financial year was INR 148.66 Lakhs.
Taxation Policy Impact
The effective tax rate for H1 FY2026 was approximately 23.6% (INR 15.78 Cr tax on INR 66.89 Cr PBT).
Legal Contingencies
The Board states there are no risks threatening the existence of the company. Specific pending court case values are not disclosed.
Risk Analysis
Key Uncertainties
Volatility in crude oil prices (raw material) and intense competition from global players are the primary business risks.
Geographic Concentration Risk
75% of revenue is concentrated in the Indian domestic market as of Q2 FY2026.
Third Party Dependencies
Dependency on raw material suppliers for imported chemicals, though specific vendor names are not disclosed.
Technology Obsolescence Risk
Risk of competitors introducing new products with enhanced capabilities; mitigated by FCL's continuous R&D and product innovation.
Credit & Counterparty Risk
Low risk due to established relationships with reputed, large-scale domestic and international clients.